Magoula I, Tsapas G, Paletas K, Mavromatidis K
Second Clinic of Internal Medicine, Aristotelian University, Hippocration Hospital, Thessaloniki, Greece.
Nephron. 1991;59(1):21-6. doi: 10.1159/000186512.
We studied 14 patients (11 women and 3 men) from 18 to 33 years old, suffering from type I diabetes mellitus with normal renal function (creatinine clearance 106.91 +/- 28.73 ml/min) and serum uric acid below 2.5 mg/dl (2.34 +/- 0.11 mg/dl) as well as a high uric acid clearance (23.04 +/- 5.92 ml/min) and fractional urate excretion (21.4 +/- 2.6) versus urate clearance 9.82 ml/min and fractional urate excretion 8.80 +/- 1.3 in 14 normal control subjects. The study of the uricosuric mechanisms was conducted by the combination of probenecid (PB) test which inhibits the reabsorption of secreted urate, and pyrazinamide (PZA) test, which inhibits its tubular secretion. The results of studies indicate that the increase in urate clearance was accounted for by increased PZA-nonsuppressible urate suggesting a decreased reabsorption of filtered urate. Increased PZA-suppressible urate excretion combined with impaired response to a uricosuric drug is consistent with impaired reabsorption of secreted urate. According to our findings, increased urate excretion in diabetic patients may be attributed to the inhibition of both filtered and secreted reabsorption. This reabsorptive tubular abnormality is consistent with the view of an interference of tubular reabsorption of glucose with the tubular capacity for uric acid reabsorption.
我们研究了14名年龄在18至33岁之间的患者(11名女性和3名男性),他们患有I型糖尿病,肾功能正常(肌酐清除率为106.91±28.73 ml/min),血清尿酸低于2.5 mg/dl(2.34±0.11 mg/dl),尿酸清除率较高(23.04±5.92 ml/min),尿酸排泄分数为(21.4±2.6),而14名正常对照受试者的尿酸清除率为9.82 ml/min,尿酸排泄分数为8.80±1.3。通过联合使用抑制分泌尿酸重吸收的丙磺舒(PB)试验和抑制尿酸肾小管分泌的吡嗪酰胺(PZA)试验,对促尿酸排泄机制进行了研究。研究结果表明,尿酸清除率的增加是由于PZA不可抑制的尿酸增加,提示滤过尿酸的重吸收减少。PZA可抑制的尿酸排泄增加,同时对促尿酸排泄药物的反应受损,这与分泌尿酸的重吸收受损一致。根据我们的研究结果,糖尿病患者尿酸排泄增加可能归因于滤过和分泌重吸收的抑制。这种肾小管重吸收异常与葡萄糖肾小管重吸收干扰尿酸肾小管重吸收能力的观点一致。